WILL BE LAUNCHED SOON!!!



The PCR kit is designed for qualitative detection of the BCR/ABL fusion gene,which is the result of a reciprocal translocation between chromosomes 9 and 22, by the real-time Polymerase Chain Reaction (PCR) method.
Detection of the three most frequent variants: Major (Mbcr), minor (mbcr) and micro (µbcr) BCR/ABL. The kit is designed for in vitro diagnostics and provides qualitative detection.



The PCR kit is designed for the BCR/ABL p190 fusion gene transcript quantification in bone marrow or peripheral blood samples by the real time Polymerase Chain Reaction (PCR) method.
The BCR/ABL gene transformation (the so-called Philadelphia chromosome) is the result of a reciprocal translocation between chromosomes 9 and 22 and it tends to be primarily diagnosed in patient with acute lymphoblastic leukemia (ALL). The test is suitable for establishing the patient's molecular response level to the applied treatment, for monitoring minimum residues of the disease in the long run and for predicting possible relapses. The kit is designed for in vitro diagnostics.



The PCR kit is designed for the BCR/ABL p210 fusion gene transcript quantification in bone marrow or peripheral blood samples by the real time Polymerase Chain Reaction (PCR) method.
The BCR/ABL gene transformation (the so-called Philadelphia chromosome) is the result of a reciprocal translocation between chromosomes 9 and 22 and it tends to be primarily diagnosed in patient with chronic myeloid leukemia (CML) and acute lymphoblastic leukemia (ALL). The test is suitable for establishing the patient's molecular response level to the applied treatment, for monitoring minimum residues of the disease in the long run and for predicting possible relapses. The kit is designed for in vitro diagnostics.